241 filings
Page 3 of 13
NT 10-Q
ny9acq0ofie
16 May 22
Notice of late quarterly filing
6:11pm
NT 10-K
5cf2chst 3zum
31 Mar 22
Notice of late annual filing
10:54am
8-K
go40 wzoa5njl
9 Mar 22
AXIM Biotech Launches For Research Use Only Sales for its COVID-19 Neutralizing Antibody Test
4:37pm
8-K
j3k8krecl5e121gfiw
16 Feb 22
Entry into a Material Definitive Agreement
4:33pm
8-K
mogb lhgk
12 Jan 22
Departure of Directors or Certain Officers
12:00am
8-K
rxapxg 5qcdpk
7 Jan 22
Departure of Directors or Certain Officers
4:21pm
NT 10-Q
x35wan6aro57w
15 Nov 21
Notice of late quarterly filing
1:28pm
NT 10-Q
ya051
16 Aug 21
Notice of late quarterly filing
12:00am
8-K
354ezh1
4 Aug 21
AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
12:00am
EFFECT
noec8
23 Jun 21
Notice of effectiveness
12:15am
CORRESP
hdam2 f5u
21 Jun 21
Correspondence with SEC
12:00am
S-1/A
94sx 6f8t
9 Jun 21
IPO registration (amended)
5:08pm
UPLOAD
ji1y54ml m0w
19 May 21
Letter from SEC
12:00am